• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ACR:AU

1.9600 AUD 0.0500 2.49%

As of 02:10:27 ET on 08/22/2014.

Snapshot for Acrux Ltd (ACR)

Open: 2.0300 Day's Range: 1.9600 - 2.0400 Volume: 2,470,444
Previous Close: 2.0100 52wk Range: 0.7500 - 3.2195 1-Yr Rtn: -36.15%

Stock Chart for ACR

No chart data available.
  • ACR:AU 1.9675
  • 1D
  • 1M
  • 1Y
2.0100
Interactive ACR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACR

Current P/E Ratio (ttm) 11.5294
Estimated P/E(06/2015) 19.4059
Relative P/E vs. AS51 0.6228
Earnings Per Share (AUD) (ttm) 0.1700
Est. EPS (AUD) (06/2015) 0.1010
Est. PEG Ratio -
Market Cap (M AUD) 326.38
Shares Outstanding (M) 166.52
30 Day Average Volume 2,139,264
Price/Book (mrq) 5.5641
Price/Sale (ttm) 6.0383
Dividend Indicated Gross Yield 5.83%
Cash Dividend (AUD) 0.0800
Dividend Ex-Date 09/04/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACR

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ACR

Acrux Limited is a specialty pharmaceutical company that develops a range of healthcare products for the global market. The Company develops transdermal drug delivery systems. The Company's products include hormone products for women's health, anti-aging skin care and haircare products as well as veterinary pharmaceutical products. The company is a Pooled Development Fund.

Ross DobinsonChairman/FounderTony Di PietroCFO/Secretary
Nina WebsterDirector:Commercial
More Company Profile & Key Executives for ACR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil